Deciphering the molecular basis of venous thromboembolism: where are we and where should we go?

被引:12
|
作者
Morange, Pierre-Emmanuel [1 ]
Tregouet, David-Alexandre [2 ]
机构
[1] Univ Mediterranean, Fac Med, INSERM, UMR S626, Marseille, France
[2] Univ Paris 06, INSERM, UMR S937, Paris, France
关键词
genetics of thrombosis and haemostasis; epidemiology; venous thrombosis; GENOME-WIDE ASSOCIATION; VON-WILLEBRAND-FACTOR; FACTOR-V-LEIDEN; ACTIVATABLE FIBRINOLYSIS INHIBITOR; QUANTITATIVE-TRAIT LOCUS; FACTOR PATHWAY INHIBITOR; COMMON GENETIC-VARIATION; COPY NUMBER VARIATION; FACTOR-XII GENE; RISK-FACTOR;
D O I
10.1111/j.1365-2141.2009.07975.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Venous thromboembolism (VTE) is a frequent disease that has a major genetic component of risk. However, known identified genetic risk factors account for <30% of idiopathic (without any environmental origin) VTE cases. This article aims to review the lessons learnt during recent decades in the field of the genetics of VTE, describe the present state-of-art methods and discuss promising themes for finding new susceptibility loci.
引用
收藏
页码:495 / 506
页数:12
相关论文
共 50 条
  • [21] Genetic contributions to anxiety disorders: where we are and where we are heading
    Ask, Helga
    Cheesman, Rosa
    Jami, Eshim S.
    Levey, Daniel F.
    Purves, Kirstin L.
    Weber, Heike
    PSYCHOLOGICAL MEDICINE, 2021, 51 (13) : 2231 - 2246
  • [22] Craniofacial genetics: Where have we been and where are we going?
    Weinberg, Seth M.
    Cornell, Robert
    Leslie, Elizabeth J.
    PLOS GENETICS, 2018, 14 (06):
  • [23] Alopecia Areata in Latin America: Where are We and Where are We Going?
    Velasquez-Lopera, Margarita M.
    Hernandez, Natalia
    Marie Jansen, Angela
    Londono Garcia, Angela
    Carolina Luna, Paula
    Rico-Restrepo, Mariana
    del Mar Saez-de-Ocariz, Maria
    Margarita Tamayo-Buendia, Maria
    Cecilia Rivitti-Machado, Maria
    DERMATOLOGY AND THERAPY, 2023, 13 (01) : 95 - 114
  • [24] The coming of age of neutrophil extracellular traps in thrombosis: Where are we now and where are we headed?
    Van Bruggen, Stijn
    Martinod, Kimberly
    IMMUNOLOGICAL REVIEWS, 2023, 314 (01) : 376 - 398
  • [25] Where are we on worms?
    Elliott, David E.
    Weinstock, Joel V.
    CURRENT OPINION IN GASTROENTEROLOGY, 2012, 28 (06) : 551 - 556
  • [26] Epidemiology of Chronic Pruritus: Where Have We Been and Where Are We Going?
    Mollanazar N.K.
    Koch S.D.
    Yosipovitch G.
    Current Dermatology Reports, 2015, 4 (1) : 20 - 29
  • [27] Pediatric Headache: Where Have We Been and Where Do We Need to Be
    Singhi, Samata
    Jacobs, Howard
    Gladstein, Jack
    HEADACHE, 2014, 54 (05): : 817 - 829
  • [28] Risk prediction of recurrent venous thrombosis; where are we now and what can we add?
    Timp, Jasmijn F.
    Lijfering, Willem M.
    Rosendaal, Frits R.
    le Cessie, Saskia
    Cannegieter, Suzanne C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2019, 17 (09) : 1527 - 1534
  • [29] Diagnosis and Treatment of Syndesmotic Unstable Injuries: Where We Are Now and Where We Are Headed
    Bejarano-Pineda, Lorena
    DiGiovanni, Christopher W.
    Waryasz, Gregory R.
    Guss, Daniel
    JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS, 2021, 29 (23) : 985 - 997
  • [30] A Historical Perspective on Sports Concussion: Where We Have Been and Where We Are Going
    Williams, Vernon B.
    Danan, Ilan J.
    CURRENT PAIN AND HEADACHE REPORTS, 2016, 20 (06)